feed,title,long_url,short_url
Benzinga,"Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz",https://benzinga.com/news/large-cap/23/04/31953000/johnson-johnson-unleashes-kenvue-tylenol-to-neutrogena-40b-revenue-unit-spinoff-preps-for-ipo-blit,https://da.gd/GZvG1
